Search consultations

Consultation

Draft Guidelines on the Right to a Decent Home in Aotearoa

NZNO warmly invites your feedback on Aratohu tika tangata ki te whai whare rawaka i Aotearoa | Guidelines on the right to a decent home in Aotearoa.

The Guidelines address the unique context of Aotearoa and Te Tiriti O Waitangi, aiming to clarify what the right to a decent home means.

Implementation of the guidelines should result in better design and delivery of housing services, thereby supporting a healthier and more socially just Aotearoa for individuals, families, hapū, whānau and communities.

Further information about the consultation is available here on the Human Rights Commission website.

Senior Policy Analyst Lucia Bercinskas will collate all responses into an NZNO submission.

Please send your feedback to PolicyAnalysts@nzno.org.nz by midday 16 December 2020.

Posted in: Consultations

Mental Health Commissioner’s Mental Health And Addiction Services Monitoring and Advocacy Framework

Short timeframe - NZNO encourages you to provide feedback on the Mental Health and Addiction Services Monitoring and Advocacy Framework. This framework will support the Mental Health and Wellbeing Commission (MHWC)’s function to monitor mental health services and addiction services and will be used to advocate for improvements to those services. 

This is an important opportunity for NZNO to provide input into the fundamentals of the monitoring framework such as:

  • Why monitor services?
  • Monitor what?
  • How to monitor?

Further information about the consultation is available on the MHWC website.

Senior Policy Analyst Lucia Bercinskas will collate all responses into an NZNO submission.

Please send your feedback to PolicyAnalysts@nzno.org.nz by midday 4 December 2020.

Posted in: Consultations

International Council of Nurses - Code of Ethics

'The International Council of Nurses (ICN) is updating its Code of Ethics for Nurses (the Code).

As an important stakeholder and partner, we are seeking your diverse perspectives and nursing advice to ensure that the Code reflects and supports current realities. Given the current challenges the world is facing, nurses have a very important role in upholding ethical standards, human rights and social justice. The ICN Code of Ethics for Nurses provides a framework to guide and support nurses. It is for this reason that your input is so valued. Please take the time to read carefully and make your contribution to this important document. This new version of the Code has already undergone a full and robust review by members of the ICN Board, as well as an Expert Steering Group. 

We are now requesting feedback from ICN members, patients organisations, regulatory bodies, educators and other global stakeholders.’

Please send feedback to sue.gasquoine@nzno.org.nz by 30 November 2020.

Posted in: Consultations

Feedback on HISO 10058.1:2020 Infection Surveillance Data Standard

NZNO welcomes your feedback on Ministry of Health’s draft Infections Surveillance Data Standard.

To support the ability to monitor the occurrence of infections or an outbreak by key organisms using an infection surveillance system, data needs to be captured consistently.

The draft Infection Surveillance Data Standard has been designed to identify the minimum information required to be captured for a patient’s health care encounter when a suspected or confirmed infection has been identified. This document covers infections identified in both the community and hospital setting.

Please find further information and the draft standard online here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 6 November 2020.

Posted in: Consultations

Feedback on the proposed regulation of home and community support services

NZNO welcomes your feedback on Ministry of Health’s consultation on the proposed regulation of the home and community support services in Aotearoa, New Zealand.

Developing the same regulatory framework for home and community support services, that exists for residential health and disability services, offers a range of opportunities to improve health outcomes.

Ministry of Health is conducting a two-phase consultation process. Further information about the consultation can be accessed here.

Please send feedback to Sue.Gasquoine@nzno.org.nz by 23 October 2020.

Posted in: Consultations

Proposal to decline inactive funding applications

NZNO welcomes your feedback on PHARMAC’s proposal to decline 59 funding applications. PHARMAC is not currently working on these applications and so plans to decline them in order to provide certainty.

You can access the list of impacted applications here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 23 October 2020.

Posted in: Consultations

Proposal to transition funded access to dornase alfa to a standard Special Authority

NZNO welcomes your feedback on PHARMAC’s proposal to transition the process for obtaining funded access to dornase alfa (Pulmozyme) from the cystic fibrosis (CF) Panel to a standard Special Authority from 1 December 2020.

The proposal involves the continuation of funding of dornase alpha for eligible patients; the main change would be to the mechanism of application for funding

Further information about the consultation can be accessed here.

If no feedback is received, NZNO will not make a submission. Please note the short timeframe.

Please send feedback to PolicyAnalysts@nzno.org.nz by 13 October 2020.

Posted in: Consultations

Proposal to widen access to sirolimus for lymphovascular malformations and tuberous sclerosis complex complications

NZNO welcomes your feedback on PHARMAC’s proposal to widen funded access to sirolimus. Funded access to sirolimus would be widened to include patients with lymphovascular malformations, renal angiomyolipoma associated with tuberous sclerosis complex (TSC) and refractory (i.e. treatment-resistant) epilepsy associated with TSC.  

We estimate that approximately 70 patients across these three indications would benefit each year from this proposal under the proposed Special Authority criteria

More information about the consultation is available here. If no feedback is received, NZNO will not make a submission.

Please note the short timeframe.

Please send feedback to PolicyAnalysts@nzno.org.nz by 13 October 2020.

Posted in: Consultations

Proposal to list medical devices supplied by Bard Australia Pty Limited

NZNO welcomes your feedback on PHARMAC’s proposal to list medical devices supplied by Bard Australia Pty Limited in the following categories:

Please find further consultation information here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 14 October 2020.

Posted in: Consultations

Proposal to list medical devices supplied by LifeHealthcare Limited

NZNO welcomes your feedback on PHARMAC’s proposal to list surgical suction, chest and wound drainage devices supplied by LifeHealthcare Limited. The proposal would result in 51 medical devices of the Serres brand being listed.

Please find further consultation information here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 8 October 2020.

Posted in: Consultations

Proposal to fund emicizumab for people with haemophilia A

NZNO welcomes your feedback on PHARMAC’s proposal to fund a new treatment, emicizumab (Hemlibra). This is for people with severe haemophilia A and inhibitors to a coagulation (clotting) factor (factor VIII). It is likely that 10 - 15 patients per year would be eligible for treatment under the proposed criteria.

As part of the consultation PHARMAC is also seeking views on whether to risk pool this medicine, which distribution arrangements to use, and what approval process to put in place.

Please find further consultation information here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 30 September 2020.

Posted in: Consultations

Proposal to fund two new medicines for type 2 diabetes

NZNZO welcomes your feedback on PHARMAC’s proposal to fund two new treatments for type 2 diabetes and amend the contractual terms for one currently funded diabetes treatment through provisional agreements with three suppliers. 

Please find further consultation information here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 25 September 2020.

Posted in: Consultations

Proposal to widen access to treatments for juvenile idiopathic arthritis

NZNO welcomes your feedback on PHARMAC’s proposal to widen access to three funded treatments, adalimumab, etanercept and tocilizumab, for the treatment of juvenile idiopathic arthritis (JIA). This is an inflammatory condition that affects the joints of children and young people. 

Access criteria for adalimumab and etanercept would be widened to include funding for treatment of oligoarticular course JIA and treatment of polyarticular course JIA affecting 5 or more joints. Access criteria for tocilizumab would be widened for polyarticular course JIA affecting 5 or more joints at the same time. 

Further information on the consultation is available here. If no feedback is received, NZNO will not make a submission. 

Please send feedback to PolicyAnalysts@nzno.org.nz by 22 September 2020. 

Posted in: Consultations

Proposal to list medical devices supplied by Jackson Allison Medical and Surgical Limited

NZNZO welcomes your feedback on PHARMAC’s proposal to list 91 medical devices supplied by Jackson Allison Medical & Surgical in the following categories:

  • obstetrics and gynaecology; and
  • rehabilitation equipment, patient positioning products and supports.

Please find further consultation information here. If no feedback is received, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 23 September 2020.

Posted in: Consultations

1345678910Last

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Email:  
Captcha:
CAPTCHA image
Enter the code shown above in the box below.